Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Tonghe Pharmaceutical Co., Ltd. (Tohope Pharmaceutical) is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and high-value intermediates. Established in 2002 and headquartered in Changshu, Jiangsu Province, the company has roots extending back to 1978 through its predecessor, Ouqu Chemical. Tohope is a global leader in the production of Alpha Lipoic Acid and its derivatives, and it also manufactures key APIs such as Metformin Hydrochloride and Febuxostat. As a subsidiary of Jiangsu Wanxing Venture Capital, the company provides CDMO services including custom synthesis and process optimization for global pharmaceutical clients. Its manufacturing facilities are GMP-certified and adhere to international quality standards, serving markets in Europe, North America, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Tonghe Pharmaceutical.